Lilly's investigative Alzheimer’s treatment slowed disease progression in late-stage trial

May 4, 2023 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Eli Lilly has announced that a late-stage trial of its investigative candidate, donanemab, significantly slowed the cognitive and functional decline in people with early symptomatic Alzheimer's disease. …

Subscribe now to continue reading.

Latest Video

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships
October 19, 2025 - Latest News
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - Latest News
Australia records worst flu season on record as vaccination rates stagnate
October 20, 2025 - Latest News
NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter
October 20, 2025 - Latest News
FOI reforms set back transparency decades and will impact public health decision-making
October 21, 2025 - Latest News

Lilly's investigative Alzheimer’s treatment slowed disease progression in late-stage trial

This is a preview of subscriber content

Latest Video

Most Read

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Australia records worst flu season on record as vaccination rates stagnate

NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter

FOI reforms set back transparency decades and will impact public health decision-making

New Stories

Sanofi treatment for ultra-rare ASMD to be made available through LSDP

Sigma reports strong growth and upgraded synergies in first full year post-merger

IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus

FOI reforms set back transparency decades and will impact public health decision-making

Astellas' XTANDI achieves landmark survival milestone in prostate cancer

Services Australia reports record number of processed PBS prescriptions

Endometriosis diagnoses in Australian GP clinics nearly double over a decade

Sign In

Lilly's investigative Alzheimer’s treatment slowed disease progression in late-stage trial

This is a preview of subscriber content

Latest Video

Most Read

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Australia records worst flu season on record as vaccination rates stagnate

NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter

FOI reforms set back transparency decades and will impact public health decision-making

Follow Us

New Stories

Sanofi treatment for ultra-rare ASMD to be made available through LSDP

Sigma reports strong growth and upgraded synergies in first full year post-merger

IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus

FOI reforms set back transparency decades and will impact public health decision-making

Astellas' XTANDI achieves landmark survival milestone in prostate cancer

Services Australia reports record number of processed PBS prescriptions

Endometriosis diagnoses in Australian GP clinics nearly double over a decade